Recalcitrant Dermatomyositis Treated With Anifrolumab
Dermatomyositis is an idiopathic inflammatory myopathy which can present with distinctive skin features. Despite the many treatment modalities for the treatment of dermatomyositis some patients remain refractory to treatment. We present a case of a 38‐year‐old man with recalcitrant dermatomyositis w...
Saved in:
Main Authors: | Shivang Chaudhary, Meghan Baumer, Laura Upton, Samantha Ong, Kristin Smith, Daniel West, Adam Kilian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | ACR Open Rheumatology |
Online Access: | https://doi.org/10.1002/acr2.11792 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of valaciclovir in preventing herpes zoster in patients receiving anifrolumab
by: Zahir Amoura, et al.
Published: (2025-01-01) -
Dual immunomodulator therapy with adalimumab and upadacitinib to treat recalcitrant hidradenitis suppurativa
by: Zahidul Islam, BA, et al.
Published: (2025-02-01) -
Physiology‐based pharmacokinetic model with relative transcriptomics to evaluate tissue distribution and receptor occupancy of anifrolumab
by: Pradeep Sharma, et al.
Published: (2025-01-01) -
A Recalcitrant Foreign Body
by: Ashley Gillson, et al.
Published: (2012-01-01) -
Mechanisms of recalcitrant fucoidan breakdown in marine Planctomycetota
by: Carla Pérez-Cruz, et al.
Published: (2024-12-01)